They concluded that elevated serum AFP levels above 7 ng/mL significantly predicted the development of HCC within one year in these patients but found that 69% of patients with cirrhosis who eventually developed HCC had serum AFP less than or equal to 7 ng/mL when they were diagnosed with HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.